ORTHOLOC 2 LAPIFUSE: payments to doctors
Payments that named ORTHOLOC 2 LAPIFUSE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.2M
- Providers
- 4,072
- Transactions
- 12,089
- Average per transaction
- $429
The per-transaction average — $429 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,072 providers the average total is $1,273, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Stryker | $5,182,058 | 100.0% |